» Articles » PMID: 21825067

Pseudomonas Aeruginosa Suppresses Interferon Response to Rhinovirus Infection in Cystic Fibrosis but Not in Normal Bronchial Epithelial Cells

Overview
Journal Infect Immun
Date 2011 Aug 10
PMID 21825067
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

Despite increased morbidity associated with secondary respiratory viral infections in cystic fibrosis (CF) patients with chronic Pseudomonas aeruginosa infection, the underlying mechanisms are not well understood. Here, we investigated the effect of P. aeruginosa infection on the innate immune responses of bronchial epithelial cells to rhinovirus (RV) infection. CF cells sequentially infected with mucoid P. aeruginosa (MPA) and RV showed lower levels of interferons (IFNs) and higher viral loads than those of RV-infected cells. Unlike results for CF cells, normal bronchial epithelial cells coinfected with MPA/RV showed higher IFN expression than RV-infected cells. In both CF and normal cells, the RV-stimulated IFN response requires phosphorylation of Akt and interferon response factor 3 (IRF3). Preinfection with MPA inhibited RV-stimulated Akt phosphorylation and decreased IRF3 phosphorylation in CF cells but not in normal cells. Compared to normal, unstimulated CF cells or normal cells treated with CFTR inhibitor showed increased reactive oxygen species (ROS) production. Treatment of CF cells with antioxidants prior to MPA infection partially reversed the suppressive effect of MPA on the RV-stimulated IFN response. Together, these results suggest that MPA preinfection inhibits viral clearance by suppressing the antiviral response particularly in CF cells but not in normal cells. Further, increased oxidative stress in CF cells appears to modulate the innate immune responses to coinfection.

Citing Articles

A cooperativity between virus and bacteria during respiratory infections.

Lalbiaktluangi C, Yadav M, Singh P, Singh A, Iyer M, Vellingiri B Front Microbiol. 2023; 14:1279159.

PMID: 38098657 PMC: 10720647. DOI: 10.3389/fmicb.2023.1279159.


IFNλ: balancing the light and dark side in pulmonary infection.

Antos D, Alcorn J mBio. 2023; 14(4):e0285022.

PMID: 37278532 PMC: 10470512. DOI: 10.1128/mbio.02850-22.


Transcriptionally active nasopharyngeal commensals and opportunistic microbial dynamics define mild symptoms in the COVID 19 vaccination breakthroughs.

Devi P, Kumari P, Yadav A, Tarai B, Budhiraja S, Shamim U PLoS Pathog. 2023; 19(2):e1011160.

PMID: 36800345 PMC: 9937460. DOI: 10.1371/journal.ppat.1011160.


Microbial and Immune Regulation of the Gut-Lung Axis during Viral-Bacterial Coinfection.

Lane S, Hilliam Y, Bomberger J J Bacteriol. 2022; 205(1):e0029522.

PMID: 36409130 PMC: 9879096. DOI: 10.1128/jb.00295-22.


Pseudomonas aeruginosa in the Cystic Fibrosis Lung.

King J, Murphy R, Davies J Adv Exp Med Biol. 2022; 1386:347-369.

PMID: 36258079 DOI: 10.1007/978-3-031-08491-1_13.


References
1.
Sapey E, Stockley R . COPD exacerbations . 2: aetiology. Thorax. 2006; 61(3):250-8. PMC: 2080749. DOI: 10.1136/thx.2005.041822. View

2.
Van Ewijk B, van der Zalm M, Wolfs T, Fleer A, Kimpen J, Wilbrink B . Prevalence and impact of respiratory viral infections in young children with cystic fibrosis: prospective cohort study. Pediatrics. 2008; 122(6):1171-6. DOI: 10.1542/peds.2007-3139. View

3.
Sajjan U, Wang Q, Zhao Y, Gruenert D, Hershenson M . Rhinovirus disrupts the barrier function of polarized airway epithelial cells. Am J Respir Crit Care Med. 2008; 178(12):1271-81. PMC: 2599868. DOI: 10.1164/rccm.200801-136OC. View

4.
Ong E, Ellis M, Webb A, Neal K, Dodd M, Caul E . Infective respiratory exacerbations in young adults with cystic fibrosis: role of viruses and atypical microorganisms. Thorax. 1989; 44(9):739-42. PMC: 462055. DOI: 10.1136/thx.44.9.739. View

5.
Sajjan U, Keshavjee S, Forstner J . Responses of well-differentiated airway epithelial cell cultures from healthy donors and patients with cystic fibrosis to Burkholderia cenocepacia infection. Infect Immun. 2004; 72(7):4188-99. PMC: 427436. DOI: 10.1128/IAI.72.7.4188-4199.2004. View